Paper Details

  1. Home
  2. Paper Details

Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.

Author: AhonenKati, HoppuKalle, HämäläinenMirja L, RantalaHeikki

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the efficacy and safety of nasal sumatriptan in treating migraine attacks in children and adolescents. The results showed that nasal sumatriptan was effective and well-tolerated in children over 8 years of age. Headache relief was achieved twice as often with sumatriptan compared to placebo. The most common side effect was a bad taste.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To investigate the efficacy of nasal sumatriptan in migraine attacks of children and adolescents. METHODS: A double-blind, placebo-controlled, two-way crossover trial was conducted in three hospital outpatient departments, with 8 to 17 year olds diagnosed with migraine serving as subject...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1212/01.wnl.0000115105.05966.a7

データ提供：米国国立医学図書館（NLM）

Nasal Sumatriptan: A Boon for Migraine in Children

This study in the field of pediatric neurology investigates the efficacy of nasal sumatriptan in treating migraine attacks in children and adolescents. The authors conducted a randomized, double-blind, placebo-controlled trial to evaluate the effectiveness and safety of this medication in a younger population.

Fighting Migraine in Young Minds

The study found that nasal sumatriptan was significantly more effective than placebo in reducing headache severity in children and adolescents experiencing migraine attacks. The medication provided headache relief in a significantly higher proportion of patients compared to placebo, with improvement observed as early as one hour after administration. The most common side effect was a bad taste after sumatriptan, but no serious adverse effects were observed.

Managing Migraine in Children: A New Avenue

This study offers encouraging news for children and adolescents suffering from migraine. It provides evidence that nasal sumatriptan can be an effective and well-tolerated treatment option for this debilitating condition. The findings highlight the importance of exploring safe and effective treatment options for migraine in younger populations.

Dr.Camel's Conclusion

This study demonstrates the efficacy and safety of nasal sumatriptan for treating migraine attacks in children and adolescents. The findings provide valuable insights into the potential of this medication for managing migraine in younger populations, offering a promising treatment option for those suffering from this debilitating condition.

Date :
  1. Date Completed 2004-07-19
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

15037686

DOI: Digital Object Identifier

10.1212/01.wnl.0000115105.05966.a7

Related Literature

Article Analysis
・Effects of sumatriptan nasal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.